Results 11 to 20 of about 1,742,640 (300)

Tetracyclines and neuromuscular disorders [PDF]

open access: yesCurrent Neuropharmacology, 2012
Tetracyclines are a class of antibiotics which could act as neuroprotective molecules in several neurological disorders, such as Huntington disease, Parkinson disease, stroke and multiple sclerosis.
Orsucci D.   +3 more
core   +3 more sources

Epigenetics of neuromuscular disorders

open access: yesEpigenomics, 2020
Neuromuscular disorders are a heterogeneous group of conditions affecting the neuromuscular system. The aim of this article is to review the major epigenetic findings in motor neuron diseases and major hereditary muscular dystrophies.
Fabio Coppedè, Coppede', F
core   +3 more sources

Neuromuscular Disorders in Pregnancy

open access: yesSeminars in Neurology, 2017
Neuromuscular disorders may present and progress differently in women than in men. During pregnancy, medication adjustment, hormonal effects, and other alterations in physiology may influence the manifestation of a variety of neuromuscular disorders. The
Christyn Edmundson, Amanda Guidon
core   +3 more sources

Transition from childhood to adulthood in neuromuscular disorders: results from the ERN EURO-NMD survey [PDF]

open access: yesOrphanet Journal of Rare Diseases
Background Neuromuscular diseases (NMDs) are rare, progressive conditions that require lifelong, multidisciplinary care. Advances in diagnosis and treatment have increased survival into adulthood, making the transition from paediatric to adult care a ...
Teresinha Evangelista   +10 more
doaj   +2 more sources

Autoantibody Testing in Neuromuscular Disorders [PDF]

open access: yes, 2022
Autoantibodies are present in many autoimmune disorders, including diseases impacting the peripheral nerve, neuromuscular junction, and muscle. Some of these autoantibodies play a vital role in pathogenesis, whereas others are unlikely to be directly ...
김승우   +3 more
core   +1 more source

The Clinical, Myopathological, and Genetic Analysis of 20 Patients With Non-dystrophic Myotonia

open access: yesFrontiers in Neurology, 2022
IntroductionNon-dystrophic myotonias (NDMs) are skeletal muscle ion channelopathies caused by CLCN1 or SCN4A mutations. This study aimed to describe the clinical, myopathological, and genetic analysis of NDM in a large Chinese cohort.MethodsWe reviewed ...
Quanquan Wang   +6 more
doaj   +1 more source

Neuromuscular disorders

open access: yesAnnals of Indian Academy of Neurology, 2019
Muralidharan Nair
doaj   +2 more sources

The genetic profile of childhood neuromuscular disorders: A single center experience [PDF]

open access: yes, 2023
Neuromuscular Diseases are a heterogeneous group of childhood disorders, and differential diagnosis can be challenging. Although there is no definitive treatment for the most of this group of diseases, early diagnosis is important with the development of
Ayaz, Akif   +6 more
core   +1 more source

Duchenne muscular dystrophy cell culture models created by CRISPR/Cas9 gene editing and their application in drug screening

open access: yesScientific Reports, 2021
Gene editing methods are an attractive therapeutic option for Duchenne muscular dystrophy, and they have an immediate application in the generation of research models. To generate myoblast cultures that could be useful in in vitro drug screening, we have
Patricia Soblechero-Martín   +11 more
doaj   +1 more source

COVID-19 in children with neuromuscular disorders. [PDF]

open access: yes, 2021
Children with neuromuscular disorders have been assumed to be a particularly vulnerable population since the beginning of COVID-19. Although this is a plausible hypothesis, there is no evidence that complications or mortality rates in neuromuscular ...
Cancho-Candela, Ramón   +15 more
core   +3 more sources

Home - About - Disclaimer - Privacy